Badalona Major Depressive Disorder Database Study

AstraZeneca

Status: Completed

Conditions: Major Depressive Disorder

Study type: Observational

Funder types: Industry

Identifiers

NCT01446692

NIS-NES-XXX-2011/2

Details and patient eligibility

About

A retrospective study using a data base of anonymized medical records. The purpose of the study is to examine the different therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care

Full description

Therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care: the Badalona database study

Enrollment: 2,260 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• An International Classification of Primary Care (ICPC-2) or DSM-IV-TR diagnosis for major depressive disorder (MDD)
• At least 8 weeks of antidepressant treatment during the identification period of 01 January 2008 - 31 December 2009
• 18 months of enrollment with medical and pharmacy records after index episode date

Trial design

2,260 participants in 2 patient groups

Patients with suboptimal response

Patients with symptomatic remission